Osaic Holdings’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.99K | Buy |
+149
| New | +$2.99K | ﹤0.01% | 6368 |
|
|
2024
Q3 | – | Sell |
-15
| Closed | -$351 | – | 7196 |
|
|
2024
Q2 | $351 | Sell |
15
-1,985
| -99% | -$46.4K | ﹤0.01% | 6867 |
|
|
2024
Q1 | $35.2K | Hold |
2,000
| – | – | ﹤0.01% | 4959 |
|
|
2023
Q4 | $27.7K | Hold |
2,000
| – | – | ﹤0.01% | 5293 |
|
|
2023
Q3 | $27.3K | Buy |
2,000
+1,000
| +100% | +$13.7K | ﹤0.01% | 5369 |
|
|
2023
Q2 | $20.4K | Buy |
+1,000
| New | +$20.4K | ﹤0.01% | 5529 |
|